FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Thursday

 

Online BrainHQ Training Program Boosts Cognition in Patients with MS, NYU Study Shows



























Image Source: GEMMLEARNING

The online BrainHQ adaptive training program developed by Posit Science is better than any computer game at helping multiple sclerosis (MS) patients improve their cognitive skills, according to a study by researchers at New York University (NYU).

The study, “Cognitive function in MS improves with telerehabilitation: Results from a randomized controlled trial,” appeared in the journal PLOS ONE.


Up to 70 percent of MS patients suffer cognitive impairment — affecting information processing, attention and learning — yet adequate treatments are lacking. Traditional rehabilitation programs in MS, such as compensatory strategies and drill-and-practice training are costly to administer in-person and require patients to travel to appointments.

In the trial (NCT02141386), researchers at NYU Langone Medical Center and NYU’s MS Comprehensive Care Centers enrolled 135 patients at Stony Brook Medicine; 74 were assigned to use the BrainHQ training, while 61 were given ordinary computer games. Patients trained an hour a day, five days a week for a total of 60 hours over a 12-week period.

Compliance was high in both groups, with the computer games group averaging 57 hours and the brain-training group averaging 38 hours. After 12 weeks, both groups showed improvement, as measured by changes in the neuropsychological Composite Score —a battery of tests that served as a primary outcome.

However, participants in the BrainHQ training program had far greater improvement in cognitive functioning than those who trained with normal computer games, even though they trained for one-third the time. The group gained about 29 percent in the overall cognitive composite score.

As a secondary measure, patients were asked to self-assess whether they felt any improvement in cognition. Of those who trained with the BrainHQ program, 56.7 percent said they had improved, compared  to 31 percent in the ordinary computer games group.

“This trial demonstrates that computer-based cognitive remediation accessed from home can be effective in improving cognitive symptoms for individuals with MS,” Leigh Charvet, the study’s lead author, said in a news release. “The remote delivery of an at-home test and findings of cognitive benefit may also be generalizable to other neurological conditions in which cognitive function is compromised.”

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length


Go to Newer News Go to Older News